comparemela.com
Home
Live Updates
Junshi Biosciences and DotBio Announce Collaboration to Develop Next-Generation Antibody Therapy with DotBody Module : comparemela.com
Junshi Biosciences and DotBio Announce Collaboration to Develop Next-Generation Antibody Therapy with DotBody Module
SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biociences Co., Ltd ("Junshi Biosciences", HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company
Related Keywords
Guangzhou ,
Guangdong ,
China ,
Zhui Feng ,
Anhui ,
Shanghai ,
Singapore ,
Suzhou ,
Jiangsu ,
Beijing ,
Maryland ,
United States ,
San Francisco ,
California ,
Chinese ,
Dotbio Pte ,
Junshi Biosciences ,
Zhi Li ,
Eli Lilly ,
Dotbio Dotbody ,
Ignacio Asial ,
Ltd Dotbio ,
Shanghai Junshi Biociences Co Ltd Biosciences ,
Ir Team ,
Pr Team ,
Chinese Academy ,
Emergency Use Authorizations ,
Junshi ,
Iosciences ,
Otbio ,
Nnounce ,
Collaboration ,
Evelop ,
Text ,
Generation ,
Ntibody ,
Therapy ,
Otbody ,
Module ,
comparemela.com © 2020. All Rights Reserved.